JP Morgan Meeting San Francisco, USA 13-17 January 2020
This author has not written his bio yet.
But we are proud to say that hearten contributed 19 entries already.
Entries by hearten
Project Manager – Chemistry Manufacturing and Control (CMC) Job Description The CMC Project Manager will support planning, tracking and communication of CMC activities to both internal and external stakeholders and partners, including designated Contract Manufacturing Organizations (CMOs). Facilitate CMC related meetings, maintain CMC project schedules and ensure alignment with cross-functional integrated timelines. Responsibilities Utilize project […]
Office Manager Job Description The Office Manager will organize and coordinate office administration and procedures, in order to ensure organizational effectiveness and efficiency. The Office Manager is responsible for developing intra-office communication protocols, streamlining administrative procedures, inventory control, office staff supervision and task delegation. Energetic professional who doesn’t mind wearing multiple hats. Experienced in handling […]
UEG Week Barcelona 2019 Barcelona, Spain 21-23 October 2019
European Association for the Study of Diabetes Barcelona, Spain 16-20 September 2019
American Diabetes Association 5-11 June 2019 San Francisco, CA Giovanni Amabile and Paolo Fiorina attending
Enthera, an innovative Italian start-up dedicated to the research and development of innovative therapeutics to treat Type 1 Diabetes and gastrointestinal diseases, received an investment of €4 million led by Sofinnova along with the JDRF T1D Fund (the venture capital fund of the authoritative US JDRF Foundation dedicated to promoting research on Type 1 Diabetes), the accelerator BiovelocITA and its shareholders.
Trianni, Inc. (“TRIANNI”) and Enthera, S.r.L. (“ENTHERA”) jointly announced today that ENTHERA has entered into a license agreement for The Trianni Mouse™, a best-in-class monoclonal antibody discovery platform.
Two research project collaborations – one in diabetes and one in oncology – have been launched, with a total investment of €2.5 million. These are the first projects launched by BiovelocITA, the Italian biotech accelerator launched last year by the chemist and entrepreneur Silvano Spinelli, Gabriella Camboni and the venture capital firm Sofinnova Partners.